Results 111 to 120 of about 23,835 (226)

Herpes Zoster Vaccination and Dementia Occurrence

open access: yesJAMA
ImportanceRecent evidence from a quasi-experiment in Wales showed that herpes zoster (HZ) vaccination appears to prevent or delay dementia. Exploiting a similar quasi-experiment in Australia, this study investigated the effect of HZ vaccination on dementia occurrence in a different population and health system setting.ObjectiveTo determine the effect ...
Pomirchy, Michael   +5 more
openaire   +3 more sources

Development of Novel Immunoassays for Varicella Zoster Virus (VZV) Vaccine and Preliminary Study on Functional Domain of ORF7 protein [PDF]

open access: yes, 2016
水痘-带状疱疹病毒(Varicella-ZosterVirus,VZV)是水痘和带状疱疹的病原体。VZV具有高度传染性,初次感染可引发水痘,并可潜伏于患者背根神经节,在年老或免疫力低下时可能激活导致带状疱疹,具有严重的危害性。接种疫苗是预防VZV感染的有效方式,但目前使用的VZV减毒活疫苗株v-Oka仍具有感染和潜伏人神经系统的能力,安全隐患不容忽视,因此,亟需研制更为安全有效的新型疫苗。高效、精确的免疫分析技术体系是研制新型疫苗的重要基础。VZV是一种基因组约125Kb,拥有70个ORF ...
刘剑
core  

Zoster vaccine live for the prevention of shingles in the elderly patient

open access: yesClinical Interventions in Aging, 2008
Jamie Zussman, Lorraine YoungDepartment of Medicine, Dermatology Division, David Geffen School of Medicine at the University of California, Los Angeles, CaliforniaAbstract: Shingles, also known as herpes zoster, is a common disease in the elderly ...
Jamie Zussman, Lorraine Young
doaj  

Periorbital cellulitis with Zoster encephalitis: a case report

open access: yesMicrobiologia Medica
Herpes Zoster, which commonly affects individuals over 60 years of age, can lead to encephalitis, particularly in elderly or immunocompromised individuals. This case highlights the development of zoster encephalitis following Herpes Zoster ophthalmicus.
Mustafa Usanmaz   +4 more
doaj   +1 more source

A Dose-Response Study of a Live Attenuated Varicella-Zoster Virus (Oka Strain) Vaccine Administered to Adults 55 Years of Age and Older [PDF]

open access: yes, 2017
Decreased cell-mediated immune (CMI) response to varicella-zoster virus (VZV) is correlated with an increased risk of reactivation of latent virus from dorsal root sites, leading to herpes zoster.
Bailleux, Fabrice   +5 more
core  

Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster

open access: yesArthritis Research & Therapy
Background Risk of cardiovascular events may increase after herpes zoster; therefore, American College of Rheumatology guidelines strongly recommend vaccination against herpes zoster in patients aged ≥ 18 years with rheumatic and musculoskeletal diseases
Jeffrey R. Curtis   +4 more
doaj   +1 more source

Immunizations - Not Just for Kids [PDF]

open access: yes, 2007
Immunizations/vaccinations are beneficial for most people of all ages. Yet the mistaken belief persists that, with the exception of the flu vaccine, children should be the primary recipients of this important area of primary disease prevention.
Harrison G. Bloom
core  

A Brazilian glycoprotein E-negative bovine herpesvirus type 1.2a (BHV-1.2a) mutant is attenuated for cattle and induces protection against wild-type virus challenge [PDF]

open access: yes
The authors previously reported the construction of a glycoprotein E-deleted (gE-) mutant of bovine herpesvirus type 1.2a (BHV-1.2a). This mutant, 265gE-, was designed as a vaccinal strain for differential vaccines, allowing the distinction between ...
Esteves, P.A.   +7 more
core   +1 more source

Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine

open access: yesnpj Vaccines
Varicella zoster virus (VZV) is a highly contagious human herpes virus responsible for causing chickenpox (varicella) and shingles (herpes zoster). Despite the approval of a highly effective vaccine, Shingrix®, the global incidence of herpes zoster is ...
Anannya Bhattacharya   +13 more
doaj   +1 more source

Mild herpes zoster after MMRV vaccination

open access: yesDeutsches Ärzteblatt international, 2021
Marc, Bienias, Reinhard, Berner
openaire   +2 more sources

Home - About - Disclaimer - Privacy